Drreddys Laboratories | RDY - Current Assets


Drreddys Laboratories reported INR297.58B in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
ANI Pharmaceuticals USD 902.82M 77.39M Sep/2026
Aurora Cannabis CAD 393.45M 4M Jun/2026
Bayer EUR 39.6B 5.96B Sep/2026
Canopy Growth CAD 506.36M 23.1M Jun/2026
Cipla INR 250.61B 9.14B Sep/2026
Corcept Therapeutics USD 533.87M 94.2M Sep/2026
Drreddys Laboratories INR 297.58B 4.4B Sep/2026
GlaxoSmithKline GBP 17.9B 336M Sep/2026
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Lonza CHF 8B 3.41B Dec/2025
Novartis USD 28.75B 1.4B Sep/2026
Pacira USD 10.3B 9.68B Sep/2026
Phibro Animal Health USD 945.17M 9.67M Sep/2026
Prestige Brands USD 492.13M 4.69M Sep/2026
Richter Gedeon HUF 803.54B 37.71B Jun/2026
Sun Pharmaceuticals INR 692.67B 54.06B Sep/2026
Supernus Pharmaceuticals USD 711.21M 12.28M Sep/2026
Teva Pharmaceutical Industries USD 14.6B 842M Sep/2026